DNA modifications in atherosclerosis: From the past to the future

Atherosclerosis

Volumn 230, Issue 2, 2013, Pages 202-209

  Borghini, Andrea ^a   Cervelli, Tiziana ^a   Galli, Alvaro ^a   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; DNA damage and repair; Environmental contaminants; Epigenetic mechanisms; Telomere shortening

Indexed keywords

MICRORNA;

APOPTOSIS; ATHEROSCLEROSIS; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL FUNCTION; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA MODIFICATION; DNA REPAIR; EPIGENETICS; EXCISION REPAIR; GENETIC PARAMETERS; HOMOLOGOUS RECOMBINATION; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; DNA DAMAGE AND REPAIR; ENVIRONMENTAL CONTAMINANTS; EPIGENETIC MECHANISMS; TELOMERE SHORTENING;

ANIMALS; ATHEROSCLEROSIS; CELL CYCLE PROTEINS; DISEASE PROGRESSION; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TELOMERE;

EID: 84884544176     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.07.038     Document Type: Review

References (82)

1. Tabas I., Williams K.J., Borén J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-1844.
2. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. NEngl J Med 2013, 368:2004-2013.
3. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
4. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
5. Pourova J., Kottova M., Voprsalova M., Pour M. Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol 2010, 198:15-35.
6. Yung L.M., Leung F.P., Yao X., Chen Z.Y., Huang Y. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 2006, 6:1-19.
7. Madamanchi N.R., Runge M.S. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007, 100:460-473.
8. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
9. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361370.
10. Hoeijmakers J.H. DNA damage, aging and cancer. NEngl J Med 2009, 361:1475-1485.
11. Winczura A., Zdzalik D., Tudek B. Damage of DNA and proteins by major lipid peroxidation products in genome stability. Free Radic Res 2012, 46:442-459.
12. Ballinger S.W., Patterson C., Yan C.N., Doan R., Burow D.L., Young C.G., et al. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000, 86:960-966.
13. Yu E., Mercer J., Bennett M. Mitochondria in vascular disease. Cardiovasc Res 2012, 95:173-182.
14. Andreassi M.G., Botto N. Genetic instability, DNA damage and atherosclerosis. Cell Cycle 2003, 2(3):224-227.
15. Araujo J. Particulate air pollution, systemic oxidative stress, inflammation, and atherosclerosis. Air Qual Atmos Health 2011, 4:79-93.
16. Andreassi M.G. DNA damage, vascular senescence and atherosclerosis. JMol Med 2008, 86:1033-1043.
17. Mahmoudi M., Mercer J., Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc Res 2006, 71:259-268.
18. Tokunaga O., Satoh T., Yamasaki F., Wu L. Multinucleated variant endothelial cells (MVECs) in human aorta: chromosomal aneuploidy and elevated uptake of LDL. Semin Thromb Hemost 1998, 24:279-284.
19. Mahmoudi M., Gorenne I., Mercer J., Figg N., Littlewood T., Bennett M. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ Res 2008, 103:717-725.
20. Izzotti A., D'Agostini F., Bagnasco M., Scatolini L., Rovida A., Balansky R.M. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res 1994, 54:1994s-1998s.
21. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., Kockx M.M. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 2001, 88:733-739.
22. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
23. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002, 106:927-932.
24. Matturri L., Cazzullo A., Turconi P., Lavezzi A.M., Vandone P.L., Gabrielli L., et al. Chromosomal alterations in atherosclerotic plaques. Atherosclerosis 2001, 154:755-761.
25. Gur M., Yilmaz R., Demirbag R., Yildiz A., Kocyigit A., Celik H., et al. Lymphocyte DNA damage is associated with increased aortic intima-media thickness. Mutat Res 2007, 617:111-118.
26. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008, 198:347-353.
27. Fadini G.P., Agostini C., Sartore S., Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194:46-54.
28. Mohamed S.A., Hanke T., Erasmi A.W., Bechtel M.J., Scharfschwerdt M., Meissner C., et al. Mitochondrial DNA deletions and the aging heart. Exp Gerontol 2006, 41:508-517.
29. Botto N., Berti S., Manfredi S., Al-Jabri A., Federici C., Clerico A., et al. Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res 2005, 570:81-88.
30. Bogliolo M., Izzotti A., De Flora S., Carli C., Abbondandolo A., Degan P. Detection of the '4977 bp' mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis 1999, 14:77-82.
31. Sabatino L., Botto N., Borghini A., Turchi S., Andreassi M.G. Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA4977 deletion in coronary artery disease patients: a link with telomere shortening. Environ Mol Mutagen 2013, [Epub ahead of print].
32. Harper J.W., Elledge S.J. The DNA damage response: ten years after. Mol Cell 2007, 28:739-745.
33. Rouse J., Jackson S.P. Interfaces between the detection, signalling, and repair of DNA damage. Science 2002, 297:547-551.
34. Harrison J.C., Haber J.E. Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 2006, 40:209-235.
35. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
36. Kuo L.J., Yang L.X. Gamma-H2AX- a novel biomarker for DNA double-strand breaks. InVivo 2008, 22:305-309.
37. Mercer J.R., Cheng K.K., Figg N., Gorenne I., Mahmoudi M., Griffin J., et al. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 2010, 107:1021-1031.
38. Pacher P., Szabo C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 2007, 25:35-60.
39. Benko R., Pacher P., Vaslin A., Kollai M., Szabo C. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. Life Sci 2004, 75:1255-1261.
40. Guarente L. Sirtuins, aging and metabolism. Cold Spring Harb Symp Quant Biol 2011, 76:81-90.
41. El Assar M., Angulo J., Vallejo S., Peiro C., Sanchez-Ferrer C.F., Rodriguez-Manas L. Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol 2012, 3:132.
42. Gorospe M., de Cabo R. AsSIRTing the DNA damage response. Trends Cell Biol 2008, 18:77-83.
43. Yuan Z., Seto E. Afunctional link between SIRT1 deacetylase and NBS1 in DNA damage response. Cell Cycle 2007, 6:2869-2871.
44. Gorenne I., Kumar S., Gray K., Figg N., Yu H., Mercer J., et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation 2012, 127:386-396.
45. de Boer J., Hoeijmakers J.H. Nucleotide excision repair and human syndromes. Carcinogenesis 2000, 3:453-460.
46. Durik M., Kavousi M., van der Pluijm I., Isaacs A., Cheng C., Verdonk K., et al. Nucleotide excision DNA repair is associated with age-related vascular dysfunction. Circulation 2012, 126:468-478.
47. Verschuren J.J.W., Trompet S., Deelen J., Stott D.J., Sattar N., Buckley B.M., et al. Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. Plos One 2013, 8:e56262.
48. Durand E., Scoazec A., Lafont A., Boddaert J., Al Hajzen A., Addad F., et al. Invivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 2004, 109:2503-2506.
49. Mercer J., Figg N., Stoneman V., Braganza D., Bennet M. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 2005, 96:667-674.
50. Clarke M.C., Littlewood T.D., Figg N., Maguire J.J., Davenport A.P., Goddard M., et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008, 102:1529-1538.
51. Clarke M., Bennett M. The emerging role of vascular smooth muscle cellapoptosis in atherosclerosis and plaque stability. Am J Nephrol 2006, 26:531-535.
52. Tabas I., Seimon T., Timmins J., Li G., Lim W. Macrophage apoptosis in advanced atherosclerosis. Ann N Y Acad Sci 2010, 1173:E40-E45.
53. Wang J.C., Bennett M. Aging and atherosclerosis. Mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012, 111:245-259.
54. Fuster J.J., Andres V. Telomere biology and cardiovascular disease. Circ Res 2006, 99:1167-1180.
55. Fyhrquist F., Saijonmaa O., Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol 2013, 10:274-283.
56. Matthews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006, 99:156-164.
57. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis:role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
58. Hoffmann J., Spyridopoulos I. Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging. Future Cardiol 2011, 7:789-803.
59. Xu S.S., Alam S., Margariti A. Epigenetics in vascular disease - therapeutic potential of new agents. Curr Vasc Pharmacol 2012, [Epub ahead of print].
60. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
61. Pons D., de Vries F.R., van den Elsen P.J., Heijmans B.T., Quax P.H., Jukema J.W. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J 2009, 30:266-277.
62. Findeisen Hannes M., Gizard Florence, Zhao Y., Qing H., Heywood E.B., Jones K.L., et al. Epigenetic regulation of vascular smooth muscle cell proliferation and Neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol 2011, 31:851-860.
63. Zentner G.E., Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 2013, 20:259-266.
64. Bao Y. Chromatin response to DNA double-strand break damage. Epigenomics 2011, 3:307-321.
65. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 15(16 Spec No 1):R50-R59.
66. Hiltunen M.O., Ylä-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol 2003, 23:1750-1753.
67. Lahtz C., Pfeifer G.P. Epigenetic changes of DNA repair genes in cancer. JMoll Cell Biol 2011, 3:51-58.
68. Baccarelli A., Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009, 21:243-251.
69. Bollati V., Baccarelli A. Environmental epigenetics. Heredity (Edinb) 2010, 105:105-112.
70. Baccarelli A., Wright R.O., Bollati V., Tarantini L., Litonjua A.A., Suh H.H., et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009, 179:572-578.
71. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
72. Raitoharju E., Lyytikainen L.P., Levula M., Oksala N., Mennander A., Tarkka M., et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219:211-217.
73. Norata G.D., Sala F., Catapano A.L., Fernandez-Hernando C. MicroRNAs and lipoproteins: a connection beyond atherosclerosis?. Atherosclerosis 2013, 227:209-215.
74. Vasa-Nicotera M., Chen H., Tucci P., Yang A.L., Saintigny G., Menghini R., et al. miR-146a is modulated in human endothelial cell with aging. Atherosclerosis 2011, 217:326-330.
75. Wan G., Mathur R., Hu X., Zhang X., Lu X. miRNA response to DNA damage. Trends Biochem Sci 2011, 36:478-484.
76. Han C., Wan G., Langley R.R., Zhang X., Lu X. Crosstalk between the DNA damage response. pathway and microRNAs. Cell Mol Life Sci 2012, 69:2895-2906.
77. Simone N.L., Soule B.P., Ly D., Saleh H.D., Savage J.E., Degraff W., et al. Ionizing radiation-induced oxidative stress alters miRNA expression. Plos One 2009, 4:e6377.
78. Lal A., Pan Y., Navarro F., Dykxhoorn D.M., Moreau L., Meire E., et al. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009, 16:492-498.
79. Hu H., Du L., Nagabayashi G., Seeger R.C., Gatti R.A. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci U S A 2010, 107:1506-1511.
80. Wu X., Song Y. Preferential regulation of miRNA targets by environmental chemicals in the human genome. BMC Genomics 2011, 12:244.
81. Babar I.A., Slack F.J., Weidhaas J.B. miRNA modulation of the cellular stress response. Future Oncol 2008, 4:289-298.
82. Guida M., Marra M., Zullo F., Guida M., Trifuoggi M., Biffali E. Association between exposure to dioxin-like polychlorinated biphenyls and miR-191 expression in human peripheral blood mononuclear cells. Mutat Res 2013, 753:36-41.